Trastuzumab and Pertuzumab (HP) in Patients With Non-Breast, Non-Gastric/GEJ, and Non-Colorectal Cancers With HER2 Amplification

Press/Media

Period4 Dec 2023

Media coverage

1

Media coverage

  • TitleTrastuzumab and Pertuzumab (HP) in Patients With Non-Breast, Non-Gastric/GEJ, and Non-Colorectal Cancers With HER2 Amplification
    Media name/outletImmunotherapy Daily
    Country/TerritoryUnited States
    Date4/12/23
    PersonsRoisin Connolly
View all 1
View less